HANTZ FINANCIAL SERVICES, INC.
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1071061
SOUTHFIELD, MI
Position in BMRN
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$640,483
+$316,293 QoQ
Shares Held
11,338
+107.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HANTZ FINANCIAL SERVICES, INC. holds $27,021,973 across 66 Biotechnology names. BMRN ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,807 | $7,951,537 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
17,673 | $5,847,465 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
61,685 | $3,986,701 | |
| 4 | ARGX |
Argenx SE
|
1,434 | $1,047,178 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
31,870 | $882,799 | |
| 6 | TECH |
BIO-TECHNE Corp
|
16,753 | $875,511 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
11,338 | $640,483 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
3,293 | $622,541 |
All Filings in BMRN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $640,483 | 11,338 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $324,190 | 5,455 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $84,218 | 1,555 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $58,048 | 1,056 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $12,865 | 182 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $7,953 | 121 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $8,505 | 121 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,421 | 78 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $6,812 | 78 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $8,677 | 90 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $7,963 | 90 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $7,801 | 90 | Shares | Sole | 2024-08-06 | |
| 2023-03-31 | $13,905 | 143 | Shares | Sole | 2024-08-06 | |
| 2022-12-31 | $14,799 | 143 | Shares | Sole | 2024-08-06 | |
| 2022-09-30 | $15,597 | 184 | Shares | Sole | 2024-08-06 | |
| 2022-06-30 | $15,496 | 187 | Shares | Sole | 2024-08-06 | |
| 2022-03-31 | $16,653 | 216 | Shares | Sole | 2024-08-06 | |
| 2021-12-31 | $977,239 | 11,061 | Shares | Sole | 2024-08-06 | |
| 2021-09-30 | $794,541 | 10,280 | Shares | Sole | 2024-08-06 | |
| 2021-06-30 | $659,259 | 7,901 | Shares | Sole | 2024-08-06 | |
| 2021-03-31 | $563,606 | 7,464 | Shares | Sole | 2024-08-06 | |
| 2020-12-31 | $699,152 | 7,973 | Shares | Sole | 2024-08-06 | |
| 2020-09-30 | $597,836 | 7,858 | Shares | Sole | 2024-08-06 | |
| 2020-06-30 | $878,920 | 7,126 | Shares | Sole | 2024-08-06 | |
| 2020-03-31 | $612,540 | 7,249 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||